Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYN domain and retroviral integrase containing | 1.5E-09 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2019 | ||||||||||
|
CPB2 antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||||||||
|
CHURC1-FNTB readthrough | 5.3E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||||
|
CSRP3 and E2F8 antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||||||||
|
long intergenic non-protein coding RNA 2741 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||||||||
|
UBX domain protein 7 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||||
|
myosin binding protein H like | 3.7E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 5 | 2012 | 2012 | ||||||||||
|
ZFP91-CNTF readthrough (NMD candidate) |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||||||||
|
BLOC-1 related complex subunit 8 | 2.6E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||||
|
macoilin 1 | 1.000 | 0.038 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2019 | ||||||||
|
collagen type XXIV alpha 1 chain | 0.931 | 0.038 | 5.0E-44 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
GEM interacting protein | 0.890 | 0.038 | 1.9E-10 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2019 | ||||||||
|
thioredoxin like 4B | 0.931 | 0.077 | 4.4E-03 |
|
phenotype | 0.100 | None | 1.000 | 4 | 1 | 2010 | 2019 | ||||||||
|
long intergenic non-protein coding RNA 1723 | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2017 | |||||||||
|
SPT2 chromatin protein domain containing 1 | 1.000 | 0.077 | 0.94 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2019 | ||||||||
|
phosphatidylcholine transfer protein | 0.861 | 0.077 | 8.8E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
EF-hand calcium binding domain 13 | 0.890 | 0.115 | 6.5E-32 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2019 | ||||||||
|
VLDLR antisense RNA 1 | 0.821 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 2 | 6 | 2012 | 2018 | |||||||||
|
complement C3b/C4b receptor 1 like | 0.931 | 0.115 | 7.6E-27 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
RAB15, member RAS oncogene family | 0.821 | 0.115 | 6.0E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
StAR related lipid transfer domain containing 9 | 0.839 | 0.115 | 1.0E-38 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
annexin A9 | 0.839 | 0.115 | 3.0E-17 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2017 | ||||||||
|
orofacial cleft 1 candidate 1 | 0.780 | 0.154 | 1.9E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
BORCS8-MEF2B readthrough | 0.780 | 0.154 | 4.0E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | ||||||||
|
forkhead box J2 | 0.821 | 0.154 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 |